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ABSTRACT 24 
 25 
There is increasing awareness that the value of peer-reviewed scientific literature 26 
is not consistent, resulting in a growing desire to improve the practice and 27 
reporting of studies. This is especially important in the field of ecotoxicology, 28 
where regulatory decisions can be partly based on data from the peer-reviewed 29 
literature, with wide-reaching implications for environmental protection. Our 30 
objective is to improve the reporting of ecotoxicology studies so that they can be 31 
appropriately utilized in a fair and transparent fashion, based on their reliability 32 
and relevance. We propose a series of nine reporting requirements, followed by a 33 
set of recommendations for adoption by the ecotoxicology community. These 34 
reporting requirements will provide clarity on the experimental design and 35 
conditions, chemical identification, test organisms, exposure confirmation, 36 
measurable endpoints, how data are presented, data availability and statistical 37 
analysis. Providing these specific details will allow for a more full assessment of 38 
the reliability and relevance of the studies, including limitations. 39 
Recommendations for the implementation of these reporting requirements are 40 
provided herein for practitioners, journals, reviewers, regulators, stakeholders, 41 
funders, and professional societies. If applied, our recommendations will improve 42 
the quality of ecotoxicology studies and their value to environmental protection. 43 
 44 
Keywords – publications, quality, reliability, relevance, risk assessment, reporting 45 
recommendations, peer review 46 
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Introduction 47 
There is widespread and growing concern that the quality, usability, and reporting 48 
of published peer-reviewed research is not as good as it could, and should, be. 49 
This can undermine the credibility and functioning of the scientific endeavor 50 
(Alberts et al., 2014; Forbes et al., 2016) and is a conversation that has spread 51 
beyond just the scientific community (e.g. The Economist, 2013). Poor science 52 
and reporting also come with steep economic costs. For example, it has been 53 
estimated that irreproducible results in the biomedical literature cost 28 billion 54 
USD in America alone, each year (Freedman et al., 2015). In addition to the 55 
direct economic costs from repeating poorly conducted studies that report 56 
spurious results, poor quality research delays and hinders protection of the 57 
environment, which is an underlying reason for conducting ecotoxicology 58 
research. By performing and reporting poor science, as a discipline we are failing 59 
to achieve our existential goal.  60 
 61 
Only recently has attention been focused on the quality of published 62 
ecotoxicology studies (e.g. Klimisch et al. 1997; Durda and Preziosi 2000; Hobbs 63 
et al. 2005; Schneider et al. 2009; Brady, 2011; Agerstrand et al. 2014; Warne et 64 
al. 2015). A core issue is that ecotoxicology studies often do not report key 65 
information required to make a judgment on the quality of the studies (Harris and 66 
Sumpter, 2015). Harris et al. (2014) suggested twelve principles that they 67 
considered should be addressed in an ecotoxicology study. They then applied 68 
three of the most objective of these principles (i.e.. measurement of exposure 69 
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concentrations, study repeated, and more than a single exposure tested) to 200 70 
randomly chosen research papers, published in 2013, in three reputable journals 71 
covering the field. They concluded the quality of published ecotoxicology 72 
research was poor, with less than half, and often less than 25%, fulfilling the 73 
criteria. In particular, often less than 25%of papers provided information 74 
demonstrating that results were repeatable, with the majority of papers reporting 75 
results from only one experiment.   76 
 77 
To further evaluate the quality of published ecotoxicology studies, we objectively 78 
assessed current reporting requirements of journals publishing ecotoxicology 79 
studies. This involved conducting an ISI Web of Science search using the topic 80 
keyword ‘ecotoxicology’, and years published ‘2014 – 2015’. The initial search 81 
generated 176 journals that published ‘ecotoxicology’ studies. We then employed 82 
a cut-off requiring greater than two ‘ecotoxicology’ articles published in 2014 –83 
2015. This cut-off left 31 journals, and for those we then screened the ‘guide to 84 
authors’ for three basic criteria we deemed fundamental to paper quality in 85 
ecotoxicology. These criteria were: 1) expectations around statistical analysis 86 
(e.g., adequate replication); 2) analytical verification of exposure concentrations; 87 
and 3) availability of Supplemental Information (as a mechanism of providing 88 
data and other information required for critical analysis of relevance and 89 
reliability). We found that relatively few journals provided guidance on our three 90 
criteria, and only one journal met all three (Figure 1). This exercise suggests that 91 
guidance on publication standards provided by peer-reviewed journals requires 92 
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improvement. We do acknowledge that many journals rely on reviewers to 93 
assess publication quality, including use of our search criteria (i.e., analytical 94 
confirmation of exposure concentrations, statistical guidance). However, relying 95 
on expert judgment alone can be problematic, as it is often inconsistently applied 96 
between reviewers (e.g., depends on the reviewers’ expertise and availability, as 97 
well as their own biases (Mahoney, 1997)) and is coupled with the needs of a 98 
journal to fill issues and increase impact factors. Baseline expectations around 99 
reporting and conductance of studies by all journals, along with mechanisms to 100 
facilitate a full review by future readers (e.g., through availability of Supplemental 101 
Information), are required in order to elevate the quality of the ecotoxicology 102 
literature as a whole (Moermond et al. 2016). 103 
 104 
Overall, the reporting of both the methodology and results in ecotoxicity studies 105 
appears to be incomplete and inadequate (Ågerstrand et al., 2011a, 2011b, 106 
2014). This can decrease the likelihood that studies are cited by other authors, or 107 
used for regulatory purposes (ECHA, 2012). Examples of missing or insufficiently 108 
reported aspects include the types and performance of controls, analytical 109 
methods and exposure confirmation, test system design, information about 110 
statistical evaluations and statistical power, and presence of possible 111 
confounding factors. As a reader of a peer-reviewed publication it can be 112 
challenging to decide whether missing information is due to insufficient reporting 113 
or inadequate design and performance of the experiment. Regardless of the 114 
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cause, missing information decreases the value of ecotoxicology publications and 115 
may lead to a paper being omitted from subsequent interpretative work. 116 
 117 
Only when studies are reported in a transparent and detailed way is it possible 118 
for a reader (e.g. a regulator who wants to use the results in the publication to 119 
ensure adequate protection of the environment) to judge the quality/reliability of 120 
the paper. Until recently, word limits of peer-reviewed journals caused authors to 121 
economize on the details of methods and materials, in order to leave room for 122 
descriptions of the results and discussion. This is no longer necessary, since it is 123 
possible to publish supporting information online where all aspects of a study can 124 
be reported in sufficient detail and raw data provided (e.g. Meyer and Francisco, 125 
2013). In this work we recommend a set of minimal reporting requirements. We 126 
then suggest a variety of strategies to maximize uptake of these requirements 127 
into all published ecotoxicology papers by those most able to create the 128 
necessary change within the peer review process (e.g., authors, journals and 129 
peer reviewers).   130 
 131 
RELEVANT REPORTING REQUIREMENTS FOR ECOTOXICITY STUDIES 132 
 133 
To ensure detailed and transparent reporting of peer-reviewed publications, 134 
reporting recommendations can be used as a tool for designing, performing, 135 
analyzing and reporting ecotoxicity studies (Ågerstrand et al., 2014; Moermond et 136 
al. 2016). This has also been suggested in other areas, e.g. in biomedical 137 
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research, to increase the value of publications and reduce waste from the 138 
reporting of poorly written research articles (Glasziou et al., 2014, Chan et al., 139 
2014). Using a systematic reporting tool also has the potential to shorten time 140 
needed for peer-review and to decrease the number of questions from peer-141 
reviewers, thereby increasing the chance of a paper getting published. It is a 142 
great loss in terms of scientific knowledge, but also from the viewpoint of animal 143 
welfare and economic resources, when peer-reviewed literature cannot be used 144 
in hazard and risk assessment of chemicals. Below we provide, in no particular 145 
order of importance, nine general reporting requirements to help enhance the 146 
quality, credibility, and usability of the ecotoxicology literature and a checklist for 147 
both authors and peer reviewers to employ when writing and assessing 148 
ecotoxicology studies (see and example in Table 1). 149 
 150 
1. Test Compound Source and Properties 151 
 152 
Test substances or products may have more than one component contributing to 153 
their toxicity and varying the amounts of these components can affect toxicity. As 154 
manufacturing processes change over time, the composition of a substance and 155 
its toxicity may also change. Ecotoxicology data derived from a historical form of 156 
a test substance may not be relevant to current forms of the test substance. As 157 
an example, the US EPA required an upper limit of 0.1% be established for DDT 158 
and its related impurities (ΣDDT, i.e. DDT, DDE and DDD) for all dicofol technical 159 
active ingredients by 1987 (US EPA, 1998). Unless otherwise specified, any data 160 
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produced prior to this date could have been conducted with technical active 161 
ingredients containing greater levels of contamination and therefore inaccurate 162 
estimates of the biological properties of the current product. 163 
 164 
In another example, the pesticide cyfluthrin contains eight isomers, of which four 165 
are more biologically active. The related pesticide, beta-cyfluthrin, only contains 166 
the four more biologically active isomers. When the isomer profile is known, the 167 
exposure and ecotoxicity of both substances can be compared by correcting for 168 
isomer-equivalents, as was done by the US EPA for the aquatic risk assessment 169 
for cyfluthrin and beta-cyfluthrin (US EPA, 2013).   170 
 171 
The following are the minimum recommended reporting requirements for test 172 
substance identification, where available: 173 
• Technical name (e.g. International Union of Pure and Applied Chemistry 174 
(IUPAC) or registration no., Chemical Abstract Service number (CAS), 175 
batch number) and formulated product, brand or trade names; 176 
• Source, purity, and composition of the test substance; specifically, percent 177 
active ingredient including levels or ratios of components and isomers and 178 
impurities 179 
 180 
Basic physico-chemical property information (e.g., aqueous solubility, acid 181 
dissociation constant (pKa), dissociation constant (Kd), octanol-water partition 182 
coefficient (Kow), organic carbon-water partition coefficient (Koc), vapour 183 
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pressure (VP) or Henry’s Law Constant (HLC), Bioconcentration Factor (BCF), 184 
Bioaccumulation Factor (BAF) and Biomagnification Factor (BMF)) can ensure 185 
studies are designed to minimize losses (e.g., volatilization, degradation or 186 
adsorption to test vessels; see Section 5 Exposure Confirmation) as well as 187 
identify the potential for chemical reactions to occur under different test 188 
conditions (e.g., ionization in relation to pH; see Section 4 Experimental 189 
Conditions).  For example it might be relevant to test: 190 
• a substance with an environmentally relevant pKa at various pHs to 191 
account for any differential uptake between its neutral and ionized form.  192 
• a rapidly degrading, volatilizing, or strongly partitioning  substance in a 193 
flow-through test system to ensure constant exposure concentrations. 194 
 195 
2. Experimental Design 196 
 197 
Details of the experimental design should be stated or, if the design is complex, a 198 
figure can often more efficiently and accurately explain the design (e.g. Figure 2 199 
from Dellinger et al., 2014). It is important that the experimental design should 200 
permit the hypothesis to be tested and the objectives to be met.  This can include 201 
incorporating test conditions and species reflective of where the data will be 202 
applied by regulators (See Section 3: Test Organism Characteristics and Section 203 
4: Experimental Conditions).  For example, the European Food Safety Authority 204 
(EFSA 2013) requires that the test conditions and species are reflective of the 205 
regions undergoing assessment, and this lack of congruency (particularly in soil 206 
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tests) has been a major factor in its rejecting certain studies in its evaluations. 207 
Experimental design features that should be reported include: 208 
• Hypotheses and objectives of the study should be clearly stated, even if 209 
the hypothesis is as simple as ‘compound X causes a 50% reduction in 210 
egg-laying relative to control at a concentration less than its aqueous 211 
solubility’.  212 
• The number of treatments and the nominal concentrations; 213 
• The number and types of controls (e.g., positive, negative, or solvent). If a 214 
solvent carrier is used then its concentration in each treatment and control 215 
should be equal and stated.  216 
• The degree of replication of each treatment and control and an 217 
explanation of whether they are true replicates or pseudo-replicates.  218 
• The methods for creating and storing the stock and working solutions and 219 
the duration of storage.  220 
• The exposure regime for the test substance (e.g. static, semi-static or 221 
flow-through) with details about the renewal regime and method. 222 
• The method/design for determining the order in which test organisms are 223 
added to test vessels and the placement of test vessels (e.g. randomized, 224 
stratified random or Latin square design).  225 
• The frequency of exposure (e.g., how often the test substance is 226 
administered or renewed) and type of samples analyzed to determine 227 
toxicant concentrations.  228 
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• Route of exposure to test organism should be clearly stated (e.g. via the 229 
diet, via the media, etc.). 230 
• Details of all quality assurance and quality control procedures conducted 231 
as part of the study (e.g. whether the design was blind or double blind, 232 
whether scoring, data entry and calculations were conducted by one, or 233 
more than one individual, and see Section 4: Experimental Conditions as 234 
they relate to water quality, etc.).  235 
 236 
3. Test Organism Characteristics 237 
 238 
Test organisms may be obtained from a variety of sources, including in-house 239 
cultures or wild populations. Providing details on where they were obtained, how 240 
they were maintained, and as much information as possible on the control 241 
performance of the test species, is useful when determining if a chemical, or 242 
mixture of chemicals causes an effect and if that effect can readily and reliably be 243 
detected. The following points should be considered and reported, where 244 
applicable: 245 
• Species selection – Justify the selected organism (e.g. ecological 246 
relevance and/or relevance to hypothesis) 247 
• Identity of the species – Report the common and scientific name of the 248 
species, general type (e.g., plant), its source, and strain (if appropriate).  249 
Provide the DNA Bar-Code details if available.  When dealing with new or 250 
cryptic species, genetic identification is recommended, e.g., the alga 251 
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Oophila sp. (Baxter et al., 2015) or the  Hyalella azteca species complex 252 
(Leung et al., 2016). 253 
• Source – In-house cultures, wild populations and, where applicable, to 254 
include method of collection (e.g., collection of fertilized eggs, or animals 255 
from the wild) and their subsequent handling. 256 
• Life-history – The stage of the life-cycle, the age and sex of the test 257 
organisms, and their size or mass at the beginning of the experiment, 258 
should be provided.  259 
• Husbandry – All procedures related to maintaining the organisms in good 260 
condition should be stated. Overviews of welfare and ethical approvals 261 
need to be reported, especially those that may influence observed 262 
responses (e.g., degree of enrichment, groupings). Outbreaks of disease 263 
or unexplained morality/morbidity, including their incidence and severity, 264 
and how these were treated, must be reported. 265 
• Test species performance – Available historical data on endpoints (e.g., 266 
growth rates, reproduction) used in the experiment should be provided, 267 
enabling the data collected during the experiment to be put into context. 268 
For example, a detectable change in growth may not be deemed 269 
biologically significant when compared to historical control data of the 270 
performing laboratory (Länge et al., 2001). Control performance should be 271 
reported in order to permit comparison to validation criteria.  272 
 273 
4. Experimental Conditions 274 
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In addition to experimental design (See Section 2: Experimental Design) the 275 
general conditions of the experiment, facilities, and operating regime should be 276 
provided, as the interaction of the test organism and testing/exposure 277 
environment influence the outcome of the study. Where applicable, the following 278 
should be reported:  279 
• General testing facilities – For example, growth chamber (make, model), 280 
tank (dimensions, capacity, rate of water change); mesocosm (location, 281 
volume, flow rate), greenhouse (location, size), field location (GPS 282 
coordinates, general climatic/environmental information, for duration of 283 
study). 284 
• Test conditions – All available details on relevant experimental parameters 285 
such as light intensity, photoperiod, and temperature should be reported 286 
as means, with the variability.   287 
• Source, type and composition of test media – e.g. water, commercially 288 
available media, soil, sediments, including known background 289 
contaminants.   290 
• Test media parameters – All measurements that can influence test 291 
organism health or change endpoint responses should be reported (e.g. 292 
dissolved oxygen concentration, temperature, pH, salinity) as means with 293 
an estimate of variability (i.e., confidence intervals).  In addition, report the 294 
properties of the test media that may influence interpretation of the test 295 
results (e.g. dissolved organic carbon where binding of test material is 296 
expected). 297 
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• Dosing mechanism – e.g. via the diet, peristaltic pump, spray application. 298 
• Details of acclimation – For both the test system and test organisms. In 299 
terms of the test system, this is to demonstrate that the conditions are 300 
stable prior to introduction of test organisms. This is of particular 301 
importance in mesocosm and sediment studies. In terms of the test 302 
organisms, this is to ensure survival and growth of test organisms during 303 
the experimental conditions (further details see Section 3 Test Organism 304 
Characteristics). 305 
• Feeding – Information should include the type of food, source, amount 306 
provided and frequency of feeding. In the case of commercial foods, 307 
detailed reporting of characteristics as required. The concentration of any 308 
contaminants should be included, where relevant. 309 
• Number and density of organisms – This may be influenced by purpose of 310 
the test or experimental design (e.g., test power, see Section 8: Statistical 311 
Analysis). However, test design should enable normal behavior of the test 312 
organism. Density of the test organisms will determine adequate feeding 313 
requirements and acceptable loading.  314 
• Good Laboratory Practices (GLP) studies – When data are from a GLP 315 
study, this should be expressly stated in the publication, as well as the 316 
location of the raw data.   317 
• Quality Assurance and Quality Control (QA/QC) activities – (e.g. 318 
calibration of laboratory equipment) and the results of these should be 319 
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reported.  If Standard Operating Procedures (SOPs) are used provide 320 
location of these.  321 
 322 
5. Exposure Confirmation 323 
Characterization of exposure in an ecotoxicity test is critical to facilitating 324 
publication, ensuring the stated hypothesis is being addressed, reducing 325 
uncertainty in the observed relationships, and allowing risk assessors to 326 
incorporate the data into their evaluations. Strong analytical support provides 327 
confidence that the stated chemical was the one that was used, that it was found 328 
in the test vessels at the concentrations targeted, in the appropriate 329 
compartments, with an understanding of the true duration of exposure. There are 330 
numerous examples in the scientific literature where the lack of analytical 331 
confirmation has resulted in erroneous conclusions, costly follow-up work, and 332 
retractions of published works (e.g., Ricaurte, 2003).  333 
 334 
What follows are minimum reporting requirements around exposure confirmation 335 
for conducting standard laboratory ecotoxicology tests, but they can also be 336 
applied to in vitro, micro- and mesocosm, and field studies. 337 
• Provide sufficient instrumental and details around your analytical 338 
approach, or a suitable reference, that supports the approach taken.   339 
• Report any relevant QA/QC undertaken during the sampling and analysis 340 
(e.g., blanks, storage studies, internal standards, recovery efficiency, and 341 
specific storage preservation techniques) and the results of the QA/QC. 342 
 16 
• Report your limits of detection, quantification, or reporting (LOD, LOQ, and 343 
LOR, respectively) and their variance.  344 
• State clearly what samples were analyzed (e.g., stocks only, exposure 345 
vessels, pooled or unpooled) and the timing or frequency of 346 
measurements.  This is important when interpreting the relevance of the 347 
observed response in light of actual exposure duration, regardless of test 348 
length. 349 
• State the media type and the volumes sampled, as well as storage 350 
conditions and time till analysis.   351 
• Report your values in metric units as the target analyte, and not as the 352 
formulated product. Where applicable, provide means of measured values 353 
and standard deviations/errors. 354 
• State clearly whether subsequent statistical analyses and interpretations 355 
rely on nominal or measured values (See Section 8), and whether these 356 
exposures values have been corrected for recovery. 357 
• Prepare a plan for archiving your original data (See Section 9). 358 
 359 
There are some scenarios where robust analytical support is not feasible or for 360 
which analytical methods below the required reporting requirements are unlikely 361 
to be met. Still, in the case of substances where routine measurements and 362 
protocols for analysis do exist, as well as very cost effective and relatively simple 363 
analytical approaches (e.g., enzyme-linked immunosorbent assay; ELISA), no 364 
standard toxicity test should be performed without some exposure confirmation. If 365 
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you are unable to provide a level of analytical support that gives risk assessor’s 366 
confidence in the data, this will seriously reflect on the value of conducting the 367 
study.   368 
 369 
6. Endpoints 370 
 371 
The reporting of information around test endpoints is especially important when 372 
assessing the relevance and reliability of the data. While endpoints, such as 373 
mortality, reproduction and growth, are familiar to the majority of ecotoxicologists, 374 
there are many that are less familiar (e.g., genomic and metabolic tools). This 375 
can lead to misunderstandings and misinterpretations of the significance and 376 
ecological relevance of the data that can and should be avoided. What follows 377 
are reporting recommendations around endpoints in ecotoxicology tests: 378 
• State all endpoints monitored in the study, regardless of the observed 379 
response (e.g., avoid reporting only ‘differences’) 380 
• Define the endpoint in order to remove ambiguity (e.g., what is a 381 
‘malformation’?) 382 
• Justify the selection of your endpoints (also see Section 2 Experimental 383 
Design) and their statistical power (see Section 8 Statistical Analysis). 384 
• Express clearly when and how the endpoint was monitored and recorded 385 
(e.g., blind evaluations of behavior; See Section 2 Experimental Design) 386 
and how these data are presented in the paper (e.g., Tables, 387 
supplemental information) 388 
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• Report other observations that may have relevance, but were not an 389 
explicit part of the original study design (e.g., lesions in fish), as this can 390 
inform future work and be hypothesis generating. 391 
 392 
7. Presentation of Results and Data 393 
 394 
Presentation of results is an important aspect of ecotoxicology that is often not 395 
discussed but has implications for assessing the utility of peer-reviewed 396 
literature. The primary purpose of Figures and Tables is to convey as much 397 
information as possible, in a manner that is simple to understand.  For excellent 398 
examples of good graphics, see Tufte (1997, 2001). It is equally important to 399 
report figures that allow an assessment of the statistical interpretation and 400 
inference. To facilitate this we recommend: 401 
• Create figures that provide readers with greater ability to assess data 402 
distributions and variability (e.g., scatterplots, histograms, box plots, etc.) 403 
for each time-point. It is common for researchers to rely upon graphs 404 
displaying a mean ± standard deviation or standard error. However, this 405 
has been shown to be problematic because different distributions of data 406 
can be represented in the exact same way when relying solely upon bar 407 
charts and line charts (Weissgerber et al. 2015). Furthermore, traditional 408 
bar charts can disguise outliers in data, which can be important, 409 
particularly for studies with small sample sizes (Weissgerber et al. 2015). 410 
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• Employ appropriate scales (e.g., do not truncate or break axes to over-411 
emphasize effect sizes or differences relative to controls). 412 
• Provide details in figure or captions specifying the statistical test employed 413 
(if applicable), degree of replication, level of statistical significance (if any). 414 
• Confidence intervals, with alpha-level, should accompany summary 415 
statistics in figures and tables, instead of standard deviation and standard 416 
error.  Confidence intervals are preferred over standard deviations or 417 
standard errors because measures of uncertainty are not always 418 
symmetric about the mean. This is especially relevant when the data are 419 
transformed for analysis and the results are expressed in back-420 
transformed values. It also applies when some non-normal error structures 421 
are used, such as Poisson or binomial. Only in the case of normally 422 
distributed data, will standard deviations provide equivalent information to 423 
confidence intervals. 424 
• Inclusion of statistically and biologically significant, as well as non-425 
significant results, will allow for a balanced understanding of the full range 426 
of responses. 427 
• It is useful to report summary data (e.g., end-points, estimates, ranges, 428 
etc.) in table-format, and greater attempts should be made to include as 429 
much data as practical, e.g., in Supplemental Information (See Section 9 430 
Raw Data). 431 
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• For field studies it is helpful to provide maps with relevant information 432 
(e.g., GPS coordinates, scale bars, orientation, regional context, etc.) that 433 
may enable a reader to understand the spatial context of a study. 434 
 435 
8. Statistical Analysis 436 
 437 
A well-conducted experiment can have its meaning distorted if poor statistical 438 
methods are used in the interpretation. Consequently, care should be taken in 439 
the selection and interpretation of statistical tests and models, and subsequent 440 
reporting of the approaches employed. Considerations include the following: 441 
• Provide a statistical flow chart that includes any preliminary data checks to 442 
satisfy test or model requirements and accommodations (e.g., 443 
transformations or robust methods) of data problems, the handling of 444 
multiple controls (e.g., solvent and negative controls), and indicate how 445 
statistical tests or models are selected and why (e.g., OECD 2006, 2010). 446 
• Provide justification for any transformations (e.g., logarithm) used and 447 
whether/how it affects the analysis results. 448 
• Power of the planned hypothesis testing procedure to find effects or the 449 
ability of a regression model to estimate ECx reliably should be reported 450 
(See Section 4: Experimental Conditions). This can be done partly through 451 
the use of historical control data (See Section 3 Test Organism 452 
Characteristics).  453 
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• Good estimation of the control mean is important since all tests and 454 
estimates are in relation to that mean, so if there were more replicates in 455 
the control than in treatment groups or other special considerations of the 456 
control, make clear what was done and why.  457 
• Statistical outliers should be identified and their effect on conclusions 458 
should be stated. 459 
• In reporting sub-lethal effects in a study with substantial mortality in high 460 
treatment groups or loss of subjects/replicates for other reasons, report 461 
any adjustments made to the tests or models (e.g., weighting) to avoid 462 
over-interpretation resulting from small sample size. 463 
• Explain how the statistics account for the actual experimental set-up (e.g., 464 
individual, paired or group housing, expected monotone dose-response or 465 
deviations therefrom, such as hormesis) 466 
• For complex models (for regression or hypothesis testing) with multiple 467 
potential explanatory variables, any model selection method that 468 
sequentially adds or removes terms to arrive at a final model should be 469 
described and, if possible, verified by alternative approaches to avoid 470 
unintentional bias.  471 
• Results should be reported in the original units and with no more 472 
significant digits than the raw data justify. For example, if the data are 473 
measured with two significant digits to the right of the decimal point, it is 474 
pointless to report means to five decimals points. That implies a level of 475 
precision not justified by the data. Moreover, the quality of the 476 
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measurements determines how many significant digits are meaningful. If 477 
the equipment being used to measure a response is accurate only to the 478 
nearest 0.1, but reports five digits past the decimal point, data should be 479 
reported only to the nearest 0.1. Summary statistics should be reported as 480 
means and confidence intervals (not standard deviations or standard 481 
errors) with an explanation of how confidence intervals were determined. 482 
This is especially important if transformed data were analyzed, so 483 
confidence intervals are not symmetric about the mean. 484 
• While expressing change from control (percent of control) is useful for 485 
presentation, data should also be presented as actual recorded values. 486 
 487 
There is disagreement about the appropriateness of calculating and 488 
implementing certain measures of toxicity, specifically no observed effect 489 
concentrations (NOECs) and lowest observed effect concentrations (LOECs) 490 
(Green et al., 2012; van Dam et al., 2012 and references therein). Still, they are 491 
necessary for some responses and datasets and are commonly used in many 492 
risk assessment frameworks, and so we have provided specific reporting 493 
requirements below.  494 
• Power to detect a specified size effect should be stated. 495 
• Confidence intervals for the mean response at the NOEC and LOEC 496 
should be reported along with the percent change from control.  497 
• If the response is non-monotonic (e.g., hormesis), indicate how this was 498 
addressed in the statistical analysis. 499 
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 500 
Effective concentrations (ECx point estimates where x is typically no more than 501 
50) also have specific reporting requirements.  These are: 502 
• Define percent change from control (the ‘x’ in ECx) as to whether it applies 503 
to raw or transformed data. 504 
• Report when ECx estimates are extrapolations, including extrapolations 505 
below the lowest tested positive concentration/dose. 506 
• Report what exposure values (e.g., measured versus nominal) were used 507 
in your estimates 508 
• Model selection and goodness-of-fit criteria should be specified.  509 
• The minimum effect size that a regression model can reliably estimate 510 
should be determined and reported. For example, if the standard error of 511 
the control mean is 20% of that mean, then the estimation of ECx for x 512 
<20 is likely unjustified.   513 
• Confidence intervals should be reported for ECx and all model parameters 514 
and explain why any parameters not significantly different from zero were 515 
included in the model, as these can indicate possible model problems. 516 
 517 
9. Raw Data 518 
 519 
Ideally, all data that are important to the determination of a toxicity value should 520 
be archived in a manner that they can later be made available for validation 521 
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and/or re-evaluation. However, the minimum data that should be archived (for 522 
example, in the Supplementary Information/material section of journals) are: 523 
• The replicate and treatment identification. 524 
• The measured and nominal chemical concentrations for each analysis. 525 
• The non-transformed (e.g., non-logged, non-normalised) biological effects 526 
data at the level of the unit of measurement. For example, data on 527 
individuals if that is what is measured or data for groups of individuals 528 
when pooled and then measured. 529 
• All measured values for experimental conditions that are known to affect 530 
the toxicity or bioavailability of the chemical. 531 
The reason for archiving the above data is to increase the usability and longevity 532 
of impact. For example, risk assessors may require the raw data of papers that 533 
are crucial to their ecological risk assessments or regulatory decision-making. 534 
They may require these data in order to re-analyse them or to confirm the 535 
estimate of toxicity, especially as risk protection goals change through time, and 536 
across jurisdictions.  537 
 538 
 539 
WHAT CAN DIFFERENT STAKEHOLDERS DO TO IMPROVE THE 540 
REPORTING AND IMPACT OF OUR SCIENCE? 541 
 542 
All of us who produce, review, publish and use ecotoxicology data play a vital 543 
role in improving the quality and reporting of our science. There are also 544 
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immense benefits to everyone involved in this endeavor should we get it right. 545 
There are a number of actions we can take now to move the discipline forward so 546 
that our shared goal of environmental protection is accomplished. 547 
 548 
A. What Journals Can Do: 549 
Some of the benefits to journals from better ecotoxicology studies would be faster 550 
peer reviews, reduced likelihood of damaging retractions, and increased impact 551 
factors. By demonstrating a commitment to the best ecotoxicology, journals can 552 
distinguish themselves from predatory publishers (Bohannon; 2013; Kolata, 553 
2013). Below, we provide advice and guidance to journal publishers, editors-in-554 
chief, associate editors, reviewers and authors. 555 
1. Journals should work with all stakeholders to create clear minimal 556 
standards for publishing ecotoxicology studies in concert with the peer 557 
review process. This could be implemented through a formal checklist for 558 
authors prior to submission. Ideally, all journals would implement the same 559 
standards. Journals could screen submissions using their checklist and if 560 
their criteria are not met, the paper will not be reviewed.   561 
2. Reporting author contributions, source of funding, and other possible 562 
conflicts of interests, with no addition to author list after submission. 563 
3. Journal training of reviewers and the use of the checklist of publishing 564 
criteria (same checklist as journal submission) to facilitate review. 565 
4. Open discussion/critique of papers and mechanisms for discussion, such 566 
as letters to the editor in online forums.  567 
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5. Create more effective mechanisms for corrections by authors, and clear 568 
reporting of retractions, with the reasons, for published papers.   569 
6. Facilitate obtaining data reported in papers (e.g., supplemental 570 
information, figures with extractable data).  Supplemental Information 571 
should download with the PDF of the paper (e.g., as it does with 572 
Proceedings of the National Academy of  Sciences, USA). 573 
7. Encourage submission of good quality papers that contain negative 574 
findings, or that replicate (or fail to) previous studies. 575 
 576 
B. What Scientists/Practitioners Can Do: 577 
The benefits of improving the conductance and reporting by scientists (whether 578 
academic, government, industry, consultants and contract labs, or non-579 
government organizations (NGOs), and students) include less time, resources 580 
and money wasted repeating previous work that was poorly performed by others, 581 
fewer animals being used, studies being reviewed more rapidly and by better 582 
journals, greater inclusion of publications in decision-making processes.  Articles 583 
with greater impact can also lead to increased funding to do more good science. 584 
To achieve these goals we recommend:  585 
1. Work towards enhancing the training of all practitioners prior to the 586 
conduction of any ecotoxicology study. 587 
2. Prior to starting the study, draw in appropriate expertise to ensure greatest 588 
possible quality (e.g., statisticians, chemists).  589 
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3. Create a checklist of a good quality study prior to commencing 590 
experimental work (see Section A: What Journals Can Do; Example in 591 
Table 1) and have a plan to meet those requirements. 592 
4. Develop internal laboratory QA/QC procedures and training. 593 
5. Attempt to verify unusual results (e.g., replicate study). 594 
6. Acknowledge the limitations of your data and do not over-interpret the 595 
results. 596 
7. Cite good quality and appropriate science. As a general rule of thumb, do 597 
not cite retracted papers. 598 
8. Have a mechanism for storing data (historical assay performance, etc.) 599 
and a means to share that with others. For example, graduate students 600 
can include raw data within their thesis appendices. 601 
9. Push for a set of consistent screening toxicity test methods across 602 
jurisdictions and standard test organisms so that replication is facilitated 603 
and these lower tier data have the widest possible uptake by regulators. 604 
With this recommendation, we are not attempting to stifle scientific inquiry, 605 
but to reduce the ambiguity that can arise when different investigators ask 606 
the same initial screening question, e.g., what is the response of the 607 
duckweed Lemna minor when exposed to a chemical? 608 
10. Become familiar with testing standards standards (e.g., Japanese Ministry 609 
of Agriculture, Forestry and Fisheries (JMAFF), Office of Chemical Safety 610 
and Pollution Prevention (OCSPP), Organisation for Economic Co-611 
operation and Development (OECD) and the American Society for Testing 612 
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and Materials (ASTM))for your test organisms, so that you are aware of 613 
performance requirements and minimal expectations around experimental 614 
design. 615 
11. Investigate whether or not regulatory bodies have criteria for evaluating 616 
published literature information (e.g., ECHA 2012, EFSA 2013, US EPA 617 
2011) and report this information in your study. 618 
12. Practitioners should gain a better understanding of GLP and its role in 619 
improving the quality of reports for risk assessment (see Borgert et al., 620 
2016).  621 
13. Encourage conversations and consultation with diverse data users (e.g. 622 
NGOs, media, industry). 623 
 624 
C. What Data Users Can Do: 625 
The benefits to data users from the better reporting of ecotoxicology includes the 626 
context required to interpret and integrate the results with all other information 627 
evaluated during a risk assessment, less uncertainty in the decision-making 628 
process, studies and data that can be used across regulatory jurisdictions, saving 629 
time and money, and positions based on data that will be more broadly accepted. 630 
It is acknowledged, however, that given the precautionary approach taken in 631 
most risk assessment frameworks, even if a study does not report all 632 
experimental details, it may still be considered if it provides information on a 633 
potential relevant risk not assessed by other data (e.g., toxicity to a non-standard 634 
sensitive species/population or vulnerable ecosystem). Those who read and use 635 
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the ecotoxicology literature, such as risk assessors, regulators, NGOs, policy 636 
makers, risk managers, scientists/practitioners play an integral role in improving 637 
the quality and reporting of ecotoxicology. This can occur through: 638 
1.  Setting and making available clear expectations for well-conducted 639 
studies, guidance to assess those studies, and the outcomes of those 640 
assessments. 641 
2. Engaging with the totality of the data and justify the inclusion/exclusion of 642 
studies and explain how information from multiple studies is assessed, 643 
weighted and integrated together. 644 
3. Consistently use and cite the best science available.  645 
4. Conduct outreach amongst practitioners and data users to communicate 646 
what your data needs are and why. 647 
5.  Work towards setting consistent toxicity test methods across jurisdictions. 648 
 649 
D. What Other Stakeholders Can Do: 650 
In this instance, we are thinking primarily of the public and media, and what they 651 
can do to help ensure better ecotoxicology. Some simple things would be to: 652 
1. Cite good quality and appropriate science in an unbiased fashion. 653 
2. Encourage consultation with the range of scientists/practitioners and data 654 
users (academics, government, industry). 655 
3. Work towards building a stronger scientific understanding of what the 656 
strengths and limitations of peer reviewed literature in general are, 657 
become comfortable with uncertainty, and acknowledge that well-658 
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conducted and reported studies will trump poorly reported and conducted 659 
studies. 660 
 661 
E. What Funders Can Do: 662 
We acknowledge that the vast majority of the ecotoxicology that is done is a 663 
result of funding, whether from government, industry, or other sources, such as 664 
NGOs.  As bodies that decide which work will be performed, it is vital they ensure 665 
that they strive to support the highest quality science, and that it is reported 666 
properly. The benefit to funders will be the creation of data that will allow for the 667 
widest reach by all users, enhancing the value of limited financial resources. To 668 
facilitate this, funders should: 669 
1. Create minimum requirements for conducting studies and reporting of data 670 
prior to funding approval. 671 
2. Provide funding so that open source publishing and repositories for raw 672 
data can be maintained. 673 
3. Promote ethics and integrity among grantees. 674 
 675 
F. What Professional Societies Can Do: 676 
Many of us involved in the field of ecotoxicology are also members of 677 
professional societies (e.g., Society of Environmental Toxicology and Chemistry) 678 
that can bring together ecotoxicologists from all stakeholder groups, as well as 679 
provide forums such as dedicated journals for the dissemination of new data.  680 
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Through these societies we can promote better conductance and reporting of 681 
ecotoxicology studies through: 682 
1. Better and ongoing training of scientists/practitioners (e.g., free short 683 
courses on best practices for the conducting and reporting of studies at 684 
annual meetings).  685 
2. Promoting ethics and integrity for students and supervisors in their 686 
research activities. 687 
3. Advocating for a set of consistent toxicity test methods across jurisdictions 688 
that will be the agreed initial screen characterization of the toxicity of a 689 
compound to a particular organism. 690 
4. Promoting civil and open discussion/critique of papers and mechanisms 691 
for discussion, such as special sessions at annual meetings. 692 
5. Ensuring society journals are working with publishers, authors, and 693 
reviewers to improve the reporting of new and negative data. 694 
 695 
DISCUSSION 696 
 697 
We believe that our recommended reporting requirements (which also inform 698 
practice), coupled with our recommendations to promote communication among 699 
users, will improve the overall quality of ecotoxicology. We acknowledge that our 700 
recommendations do not begin to address adequately the issue of relevance for 701 
the studies themselves (i.e., asking the right question). However, when a user of 702 
ecotoxicology data has identified a series of studies as highly relevant, our 703 
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recommendations should help him or her to distinguish those that are of the 704 
greatest quality and how well they have been performed to address the question 705 
of interest (i.e., what is the reliability (aka quality) of the data). We also 706 
acknowledge that the requirements we propose are neither definitive nor fixed. 707 
As the types of studies we conduct change (e.g., new protocols, new classes of 708 
chemicals of concern, in silico methods) the reporting requirements might change 709 
as well. Finally, we acknowledge the need in some cases for exclusivity of data 710 
and feel this is a question of striking the right balance. An appropriate mechanism 711 
(e.g., registration protections without the need to keep data from competitors or 712 
designating a neutral third party to handle any sensitive information) for sharing 713 
can be created so that proprietary data generated for risk assessment and 714 
regulators can be examined by all stakeholders. Regulatory agencies are tasked 715 
with making scientifically-informed decisions on behalf of the public, and 716 
therefore need to use and be seen using data of the highest quality, but also 717 
communicating why those data are selected, to ensure public trust and reduce 718 
perceptions of possible bias (Forbes et al., 2016). 719 
 720 
In summary, we have identified crucial areas where the quality of research and 721 
publication can be strengthened. These have been addressed through a set of 722 
broad recommendations for everyone involved in the discipline. If these are 723 
applied, ecotoxicology and its application in environmental protection will 724 
improve. 725 
 726 
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 890 
FIGURES 891 
 892 
 893 
 894 
 895 
 896 
Figure 1: Number of journals that provide reporting requirements of 1) 897 
expectations around statistical analysis (blue circle), 2) confirmation of exposure 898 
concentrations (yellow circle), and 3) availability of supplemental data (green 899 
circle). Journals were selected using an ISI Web of Science search using the 900 
topic keyword ‘ecotoxicology’, and years published ‘2014 – 2015’ (n = 172).  901 
Journals were further required to publish more than two ‘ecotoxicology’ articles in 902 
2014 – 2015 (n = 31).  903 
 904 
  905 
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Table 1: 906 
The model checklist provided below will assist authors and peer reviewers of 907 
ecotoxicology studies to improve their reporting and assessment. 908 
Reporting Requirement Met? 
1. Test Compound Source and Properties 
Source and purity provided?  
Technical name?  
 
2. Experimental Design 
Hypotheses, if any, stated?  
Number of treatments and their exposure levels?  
Number and type of controls?  
Duration of exposures?  
Number of replicates?  
 
3. Test Organism Characteristics 
Name, source, and strain of species reported?  
Control performance criteria met?  
Husbandry protocols listed?  
 
4. Experimental Conditions 
General test conditions reported?  
Source and condition of media?  
Acclimation and feeding?  
 
5. Exposure Confirmation 
Clear statement of which samples were analyzed?  
Method LOD and LOQ provided?  
Nominal or measured used in subsequent analyses?  
 
6. Endpoints 
All endpoints monitored, regardless of response, provided?  
Clear definitions and measurement units provided?  
 
7. Presentation of Results and Data 
All data, regardless of statistical significance is discussed?  
Untransformed data provided?  
 
8. Statistical Analysis 
Statistical flowchart?  
Transformations justified?  
All outliers are reported  
Justification for model selection and variables?  
NOE-LOEC: power of test and percent change reported?  
ECx: Model estimates and confidence intervals provided?  
 
9. Raw Data 
Nominal and measured concentrations provided?  
Untransformed response by replicate available in some form?  
  
 909 
